Jazz Pharmaceuticals PLC (NASDAQ:JAZZ) updated its FY16 earnings guidance on Monday. The company provided earnings per share guidance of $ 9.90-10.30 for the period, compared to the Thomson Reuters consensus earnings per share estimate of $ 10.02. The company issued revenue guidance of $ 1.485-1.53 billion, compared to the consensus revenue estimate of $ 1.49 billion. A number of […]
Sports Perspectives
Showing posts with label Guidance. Show all posts
Showing posts with label Guidance. Show all posts
Monday, January 9, 2017
Jazz Pharmaceuticals PLC (JAZZ) Updates FY16 Earnings Guidance
Subscribe to:
Posts (Atom)